Lv5
1108 积分 2024-03-05 加入
Antibody–drug conjugates come of age in oncology
21天前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
PF-08046876, a differentiated integrin beta-6 antibody-drug conjugate delivering a potent camptothecin payload optimized for bystander effect and reduced drug efflux
1个月前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
1个月前
已完结
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates
2个月前
已完结
Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses
2个月前
已完结
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy
4个月前
已完结
Data from HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety Profiles
4个月前
已完结
An exatecan derivative based linker-payload platform leads to ADC products with promising anti-tumor efficacy and potential low interstitial lung disease (ILD) risk
4个月前
已完结
Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
4个月前
已完结
皖公网安备34019202002308
